1. Kugathasan S; Denson LA; Walters TD; Kim MO; Marigorta UM; Schirmer M; Mondal K; Liu C; Griffiths A; Noe JD. Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. The Lancet. 2017; 389:1710-1718.
  2. Camp JG; Sekine K; Gerber T; Loeffler-Wirth H; Binder H; Gac M; Kanton S; Kageyama J; Damm G; Seehofer D. Multilineage communication regulates human liver bud development from pluripotency. Nature. 2017; 546:533-538.
  3. Turpin W; Espin-Garcia O; Xu W; Silverberg MS; Kevans D; Smith MI; Guttman DS; Griffiths A; Panaccione R; Otley A. Association of host genome with intestinal microbial composition in a large healthy cohort.. Nature Genetics. 2016; 48:1413-1417.
  4. Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients. Gastroenterology. 2017; 152:1345- 1357.e7.
  5. Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I; MP-101-06 Investigators. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis. Gastroenterology. 2017; 152:776-786.e5.
  6. Brant SR; Okou DT; Simpson CL; Cutler DJ; Haritunians T; Bradfield JP; Chopra P; Prince J; Begum F; Kumar A. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology. 2017; 152:206-217.e2.
  7. Schwimmer JB; Lavine JE; Wilson LA; Neuschwander-Tetri BA; Xanthakos SA; Kohli R; Barlow SE; Vos MB; Karpen SJ; Molleston JP. In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores. Gastroenterology. 2016; 151:1141- 1154.e9.
  8. Denson LA; Klein C. Granulocyte-Macrophage Colony Stimulating Factor Bioactivity and Mucosal Homeostasis in Crohn's Disease: A Role for Genetic Variation. Gastroenterology. 2016; 151:593-596.
  9. Vos MB; Kaar JL; Welsh JA; Van Horn LV; Feig DI; Anderson CAM; Patel MJ; Cruz Munos J; Krebs NF; Xanthakos SA. Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.. Circulation. 2017; 135:e1017-e1034.
  10. Inge TH; Jenkins TM; Xanthakos SA; Dixon JB; Daniels SR; Zeller MH; Helmrath MA. Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis. Lancet Diabetes and Endocrinology. 2017; 5:165-173.
  11. Morris DW; Stucke EM; Martin LJ; Abonia JP; Mukkada VA; Putnam PE; Rothenberg ME; Fulkerson PC. Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 2016; 138:915-918.e5.
  12. Wang KS; Tiao G; Bass LM; Hertel PM; Mogul D; Kerkar N; Clifton M; Azen C; Bull L; Rosenthal P. Analysis of Surgical Interruption of the Enterohepatic Circulation as a Treatment for Pediatric Cholestasis. Hepatology. 2017; 65:1645-1654.
  13. Lages CS; Simmons J; Maddox A; Jones K; Karns R; Sheridan R; Shanmukhappa SK; Mohanty S; Kofron M; Russo P. The Dendritic Cell-T Helper 17-Macrophage Axis Controls Cholangiocyte Injury and Disease Progression in Murine and Human Biliary Atresia. Hepatology. 2017; 65:174-188.
  14. Verkade HJ; Bezerra JA; Davenport M; Schreiber RA; Mieli-Vergani G; Hulscher JB; Sokol RJ; Kelly DA; Ure B; Whitington PF. Biliary atresia and other cholestatic childhood diseases: Advances and future challenges. Journal of Hepatology. 2016; 65:631-642.
  15. Leung DH; Heltshe SL; Borowitz D; Gelfond D; Kloster M; Heubi JE; Stalvey M; Ramsey BW; Stecenko A; Schechter M. Effects of Diagnosis by Newborn Screening for Cystic Fibrosis on Weight and Length in the First Year of Life. JAMA Pediatrics. 2017; 171:546-554.
  16. Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease. JAMA Pediatrics. 2016; 170:e161971.
  17. Mishra R; Chesi A; Cousminer DL; Hawa MI; Bradfield JP; Hodge KM; Guy VC; Hakonarson H; Mauricio D; Schloot NC. Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes. BMC Medicine. 2017; 15:88.
  18. Dellon ES; Collins MH; Bonis PA; Leung J; Capocelli KE; Dohil R; Falk GW; Furuta GT; Menard-Katcher C; Gupta SK. Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders. Clinical Gastroenterology and Hepatology. 2016; 14:1842-1844.
  19. Trout AT; Dillman JR; Xanthakos S; Kohli R; Sprague G; Serai S; Mahley AD; Podberesky DJ. Prospective Assessment of Correlation between US Acoustic Radiation Force Impulse and MR Elastography in a Pediatric Population: Dispersion of US Shear-Wave Speed Measurement Matters. Radiology. 2016; 281:544-552.
  20. Harrison SA; Marri SR; Chalasani N; Kohli R; Aronstein W; Thompson GA; Irish W; Miles MV; Xanthakos SA; Lawitz E. Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis. Alimentary Pharmacology and Therapeutics. 2016; 44:1183-1198.
  21. Nelson JE; Handa P; Aouizerat B; Wilson L; Vemulakonda LA; Yeh MM; Kowdley KV; Abrams SH; Himes R; Krisnamurthy R. Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms. Alimentary Pharmacology and Therapeutics. 2016; 44:1253-1264.
  22. Moshkovits I; Reichman H; Karo-Atar D; Rozenberg P; Zigmond E; Haberman Y; Ben Baruch-Morgenstern N; Lampinen M; Carlson M; Itan M. A key requirement for CD300f in innate immune responses of eosinophils in colitis. Mucosal immunology. 2017; 10:172-183.
  23. Asai A; Aihara E; Watson C; Mourya R; Mizuochi T; Shivakumar P; Phelan K; Mayhew C; Helmrath M; Takebe T. Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells. Development (Cambridge). 2017; 144:dev.142794.
  24. Koike H; Zhang RR; Ueno Y; Sekine K; Zheng YW; Takebe T; Taniguchi H. Nutritional modulation of mouse and human liver bud growth through a branched-chain amino acid metabolism. Development (Cambridge). 2017; 144:1018-1024.
  25. Hsu EK; Bucuvalas J. The Trouble With Exceptional Exceptions. American Journal of Transplantation. 2016; 16:3073-3074.